Registry study for kidney tumor treatment choices
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study is a registry that collects information on how people with localized kidney tumors are treated (either active treatment or watchful waiting). It may help doctors better understand which approaches work best for different patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older).
- You have been diagnosed by scans with a kidney tumor that can be treated actively or followed with watchful waiting.
- You agree to take part and sign the informed consent form.
- Your kidney cancer is not urothelial kidney cancer (a specific cancer type).
- You must be willing to participate in clinical research (not refuse).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gathers information from adult patients with kidney cancer to support a kidney cancer research network. Your information may help researchers better understand the disease and improve future care.
This trial compares two standard treatments for small kidney tumors: removing the tumor surgically (resection) or destroying it with heat or cold (ablation). The goal is to see which approach works better for tumors 3 cm or smaller.
This study follows people with small, solid kidney tumors using active surveillance (regular monitoring) rather than immediate surgery or treatment. It may help you understand whether careful watching is a safe option for certain early kidney tumors.
This study looks at a specific genetic change in kidney tumors in children, teens, and young adults up to age 30. It aims to understand how that change affects patients who are newly diagnosed or whose cancer has come back, and may guide future care.
This study follows people with kidney cancer who are scheduled for surgery to remove their tumor. It aims to learn more about the disease and how it behaves over time.
This study tests whether closely monitoring small kidney tumors (less than 4 cm) with regular imaging is a safe and effective option for people who cannot or choose not to have immediate treatment. It involves a biopsy at the start to confirm the tumor type.
Hear when a new Kidney Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.